Skip to main content
. 2014 Jan 3;14:3. doi: 10.1186/1471-230X-14-3

Table 1.

Serum PG I and II levels in various gastric disorders (n = 282)

Group N PG I (μg/L) PG II (μg/L) PG I/PG II
Healthy controls
34
118.39 ± 47.80
12.39 ± 5.90
11.74 ± 6.23
Non-atrophic gastritis
55
112.46 ± 51.71
12.57 ± 5.98
10.63 ± 5.74
Atrophic gastritis
20
93.63 ± 49.34
10.85 ± 4.58
11.07 ± 5.78
Early gastric cancer
13
71.48 ± 28.78‡▼
14.22 ± 4.90
5.19 ± 1.70‡†
Advanced gastric cancer
69
53.39 ± 34.03‡†
12.29 ± 5.63
4.88 ± 3.76‡†
 Gastric ulcer
36
147.58 ± 57.81▲†
15.60 ± 13.42
14.47 ± 13.02
 Duodenal ulcer
31
217.43 ± 51.12‡†
21.90 ± 19.45▲†
18.57 ± 16.63▲†
Gastrectomy
23
40.70 ± 15.38‡*
8.52 ± 4.52
4.43 ± 2.38
Recurrence after gastrectomy 1 289.32 65.89 4.39

Data were shown as mean ± SD.

p < 0.005, p < 0.05 vs. Healthy controls; p < 0.005, p < 0.05 vs. NAG; *p < 0.05 vs. CAG.